IOVANCE BIOTHERAPEUTICS, INC. Bonus & Incentive Agreements
18 Contracts & Agreements
- Iovance Biotherapeutics, Inc. 2018 Equity Incentive Plan, as amended (Filed With SEC on August 8, 2024)
- Iovance Biotherapeutics, Inc. 2018 Equity Incentive Plan, as amended (Filed With SEC on May 9, 2024)
- Iovance Biotherapeutics, Inc. 2018 Equity Incentive Plan, as amended (Filed With SEC on November 7, 2023)
- Form of Deferred Stock Unit Notice and Deferred Stock Unit Agreement under the Iovance Biotherapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on August 4, 2022)
- Iovance Biotherapeutics, Inc. 2018 Equity Incentive Plan, as amended (Filed With SEC on August 4, 2022)
- Form of Nonqualified Stock Option Award Agreement under the Iovance Biotherapeutics, Inc. 2018 Equity Incentive Plan, as amended (June 2021 Retention Equity Awards) (Filed With SEC on August 5, 2021)
- Form of Stock Unit Notice and Stock Unit Agreement under the Iovance Biotherapeutics, Inc. 2018 Equity Incentive Plan, as amended (June 2021 Retention Equity Awards) (Filed With SEC on August 5, 2021)
- Iovance Biotherapeutics, Inc. 2018 Equity Incentive Plan, as amended (Filed With SEC on June 9, 2020)
- Form of Non-Qualified Stock Option Agreement under the Iovance Biotherapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on February 25, 2020)
- Form of Incentive Stock Option Agreement under the Iovance Biotherapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on February 25, 2020)
- Form of Non-Qualified Stock Option Agreement under the Lion Biotechnologies, Inc. 2014 Equity Incentive Plan (Filed With SEC on February 25, 2020)
- Form of Incentive Stock Option Agreement under the Lion Biotechnologies, Inc. 2014 Equity Incentive Plan (Filed With SEC on February 25, 2020)
- Form of Non-Qualified Stock Option Agreement under the Genesis Biopharma Inc. 2011 Equity Incentive Plan (Filed With SEC on February 25, 2020)
- Form of Incentive Stock Option Agreement under the Genesis Biopharma Inc. 2011 Equity Incentive Plan (Filed With SEC on February 25, 2020)
- Form of NQSO Stock Option Agreement under the 2018 Equity Incentive Plan (Filed With SEC on August 7, 2018)
- Form of ISO Stock Option Agreement under the 2018 Equity Incentive Plan (Filed With SEC on August 7, 2018)
- LION BIOTECHNOLOGIES, INC. 2017 CORPORATE GOALS—CASH BONUS PLAN (Filed With SEC on March 9, 2017)
- GENESIS BIOPHARMA, INC. 2011 EQUITY INCENTIVE PLAN (Filed With SEC on October 20, 2011)
